Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2000 4
2001 1
2002 3
2003 2
2004 5
2005 4
2006 7
2007 6
2008 6
2009 7
2010 6
2011 14
2012 19
2013 16
2014 14
2015 20
2016 20
2017 22
2018 27
2019 20
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

199 results
Results by year
Filters applied: . Clear all
Page 1
Brain health: time matters in multiple sclerosis.
Giovannoni G, Butzkueven H, Dhib-Jalbut S, Hobart J, Kobelt G, Pepper G, Sormani MP, Thalheim C, Traboulsee A, Vollmer T. Giovannoni G, et al. Among authors: Butzkueven H. Mult Scler Relat Disord. 2016 Sep;9 Suppl 1:S5-S48. doi: 10.1016/j.msard.2016.07.003. Epub 2016 Jul 7. Mult Scler Relat Disord. 2016. PMID: 27640924 Free article. Review.
Defining secondary progressive multiple sclerosis.
Lorscheider J, Buzzard K, Jokubaitis V, Spelman T, Havrdova E, Horakova D, Trojano M, Izquierdo G, Girard M, Duquette P, Prat A, Lugaresi A, Grand'Maison F, Grammond P, Hupperts R, Alroughani R, Sola P, Boz C, Pucci E, Lechner-Scott J, Bergamaschi R, Oreja-Guevara C, Iuliano G, Van Pesch V, Granella F, Ramo-Tello C, Spitaleri D, Petersen T, Slee M, Verheul F, Ampapa R, Amato MP, McCombe P, Vucic S, Sánchez Menoyo JL, Cristiano E, Barnett MH, Hodgkinson S, Olascoaga J, Saladino ML, Gray O, Shaw C, Moore F, Butzkueven H, Kalincik T; MSBase Study Group. Lorscheider J, et al. Among authors: Butzkueven H. Brain. 2016 Sep;139(Pt 9):2395-405. doi: 10.1093/brain/aww173. Epub 2016 Jul 7. Brain. 2016. PMID: 27401521 Clinical Trial.
Vitamin D for the treatment of multiple sclerosis: a meta-analysis.
McLaughlin L, Clarke L, Khalilidehkordi E, Butzkueven H, Taylor B, Broadley SA. McLaughlin L, et al. Among authors: Butzkueven H. J Neurol. 2018 Dec;265(12):2893-2905. doi: 10.1007/s00415-018-9074-6. Epub 2018 Oct 3. J Neurol. 2018. PMID: 30284038 Review.
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, Van Pesch V, Sola P, Ferraro D, Grand'Maison F, Terzi M, Lechner-Scott J, Flechter S, Slee M, Shaygannejad V, Pucci E, Granella F, Jokubaitis V, Willis M, Rice C, Scolding N, Wilkins A, Pearson OR, Ziemssen T, Hutchinson M, Harding K, Jones J, McGuigan C, Butzkueven H, Kalincik T, Robertson N; MSBase Study Group. Brown JWL, et al. Among authors: Butzkueven H. JAMA. 2019 Jan 15;321(2):175-187. doi: 10.1001/jama.2018.20588. JAMA. 2019. PMID: 30644981 Free PMC article. Clinical Trial.
Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure.
Geissbühler Y, Vile J, Koren G, Guennec M, Butzkueven H, Tilson H, MacDonald TM, Hellwig K. Geissbühler Y, et al. Among authors: Butzkueven H. Ther Adv Neurol Disord. 2018 Nov 3;11:1756286418804760. doi: 10.1177/1756286418804760. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 30542374 Free PMC article.
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.
Kalincik T, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Lechner-Scott J, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Solaro C, Grand'Maison F, Hupperts R, Prevost J, Sola P, Ferraro D, Terzi M, Butler E, Slee M, Kermode A, Fabis-Pedrini M, McCombe P, Barnett M, Shaw C, Hodgkinson S, Butzkueven H; MSBase Study Group. Kalincik T, et al. Among authors: Butzkueven H. Mult Scler. 2018 Oct;24(12):1617-1626. doi: 10.1177/1352458517728812. Epub 2017 Aug 31. Mult Scler. 2018. PMID: 28857680 Clinical Trial.
Treatment decisions in multiple sclerosis - insights from real-world observational studies.
Trojano M, Tintore M, Montalban X, Hillert J, Kalincik T, Iaffaldano P, Spelman T, Sormani MP, Butzkueven H. Trojano M, et al. Among authors: Butzkueven H. Nat Rev Neurol. 2017 Feb;13(2):105-118. doi: 10.1038/nrneurol.2016.188. Epub 2017 Jan 13. Nat Rev Neurol. 2017. PMID: 28084327 Review.
Prognosticating autoimmune encephalitis: A systematic review.
Broadley J, Seneviratne U, Beech P, Buzzard K, Butzkueven H, O'Brien T, Monif M. Broadley J, et al. Among authors: Butzkueven H. J Autoimmun. 2019 Jan;96:24-34. doi: 10.1016/j.jaut.2018.10.014. Epub 2018 Oct 26. J Autoimmun. 2019. PMID: 30595145 Review.
Head-to-head drug comparisons in multiple sclerosis: Urgent action needed.
Tur C, Kalincik T, Oh J, Sormani MP, Tintoré M, Butzkueven H, Montalban X. Tur C, et al. Among authors: Butzkueven H. Neurology. 2019 Oct 29;93(18):793-809. doi: 10.1212/WNL.0000000000008319. Epub 2019 Oct 7. Neurology. 2019. PMID: 31591277 Review.
199 results
Jump to page
Feedback